Search

Your search keyword '"Ohki, Kentaro"' showing total 425 results

Search Constraints

Start Over You searched for: Author "Ohki, Kentaro" Remove constraint Author: "Ohki, Kentaro"
425 results on '"Ohki, Kentaro"'

Search Results

52. A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

55. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial

56. Threshold theorem in isolated quantum dynamics with stochastic control errors.

60. phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20)

62. Genetic features of B‐cell lymphoblastic lymphoma withTCF3‐PBX1

69. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2Drearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

70. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1‐RUNX1T1 transcripts

71. Genetic features of B‐cell lymphoblastic lymphoma with TCF3‐PBX1.

72. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia

76. A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma

77. ATRT-11. PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS

78. NUTM1-Rearranged Infant and Pediatric B Cell Precursor Acute Lymphoblastic Leukemia: A Good Prognostic Subtype Identified in a Collaborative International Study

79. High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors

80. B-Cell Precursor–Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review

81. An invitation to quantum filtering and smoothing theory based on two inner products (Building Foundations for Quantum Statistical Modeling)

83. Characteristics of genetic alterations of peripheral T‐cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).

84. The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II Study

85. DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes

86. Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B copy Number Alterations

87. Acute Lymphoblastic Leukemia with Zinc-Finger Protein 384 (ZNF384)-Related Rearrangements: A Retrospective Analysis from the Ponte Di Legno Childhood ALL Working Group

88. Recurrent Gene Mutations in Pediatric Patients with AML By Targeted Sequencing ―the Jccg Study, JPLSG AML-05―

89. Significant Features of DNA Methylation at Bivalent Promotor and Repressed Polycomb Regions in Pediatric AML-the Jccg Study, JPLSG AML-05-

90. Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup

91. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome

94. Very late relapse cases of TCF3‐ZNF384 ‐positive acute lymphoblastic leukemia

97. NUDT15variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia

98. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04‐16.

99. Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup.

100. Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05

Catalog

Books, media, physical & digital resources